4M0 Stock Overview
PCAS SA develops and produces complex molecules for life sciences and specialty chemicals markets.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
PCAS SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €7.80 |
| 52 Week High | €8.55 |
| 52 Week Low | €5.40 |
| Beta | 0.37 |
| 1 Month Change | 0% |
| 3 Month Change | 1.96% |
| 1 Year Change | 11.75% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -42.22% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4M0 | DE Life Sciences | DE Market | |
|---|---|---|---|
| 7D | 0% | -0.8% | -0.4% |
| 1Y | 11.7% | -12.0% | 4.2% |
Return vs Industry: 4M0 exceeded the German Life Sciences industry which returned -22.5% over the past year.
Return vs Market: 4M0 exceeded the German Market which returned 5.9% over the past year.
Price Volatility
| 4M0 volatility | |
|---|---|
| 4M0 Average Weekly Movement | 5.2% |
| Life Sciences Industry Average Movement | 6.0% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 4M0 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4M0's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | 1,178 | Jean-Louis Martin | www.pcas.com |
PCAS SA develops and produces complex molecules for life sciences and specialty chemicals markets. The company was founded in 1962 and is headquartered in Longjumeau, France. PCAS SA is a subsidiary of Seqens SAS
PCAS SA Fundamentals Summary
| 4M0 fundamental statistics | |
|---|---|
| Market cap | €109.93m |
| Earnings (TTM) | €8.76m |
| Revenue (TTM) | €229.96m |
12.5x
P/E Ratio0.5x
P/S RatioIs 4M0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4M0 income statement (TTM) | |
|---|---|
| Revenue | €229.96m |
| Cost of Revenue | €81.51m |
| Gross Profit | €148.45m |
| Other Expenses | €139.69m |
| Earnings | €8.76m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.64 |
| Gross Margin | 64.55% |
| Net Profit Margin | 3.81% |
| Debt/Equity Ratio | 2,725.7% |
How did 4M0 perform over the long term?
See historical performance and comparison